Literature DB >> 9496273

Escherichia coli and ulcerative colitis.

D Burke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496273      PMCID: PMC1296671          DOI: 10.1177/014107689709001106

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  37 in total

1.  Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis.

Authors:  D A Burke; S A Clayden; A T Axon
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

2.  Treatment of ulcerative colitis by implantation of normal colonic flora.

Authors:  J D Bennet; M Brinkman
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

3.  Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis.

Authors:  H von Wulffen; H Rüssmann; H Karch; T Meyer; M Bitzan; T C Kohrt; S Aleksic
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

4.  Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.

Authors:  D A Burke; A T Axon
Journal:  BMJ       Date:  1988-07-09

5.  Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli.

Authors:  C M Hunt; J A Harvey; E R Youngs; S T Irwin; T M Reid
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

6.  Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

Authors:  R W Chapman; W S Selby; D P Jewell
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

7.  HeLa cell and buccal epithelial cell adhesion assays for detecting intestinal Escherichia coli with adhesive properties in ulcerative colitis.

Authors:  D A Burke; A T Axon
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

8.  Sulphasalazine does not select for Escherichia coli with adhesive properties in ulcerative colitis.

Authors:  D A Burke; S A Clayden; A T Axon
Journal:  Lancet       Date:  1988-10-22       Impact factor: 79.321

9.  Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis.

Authors:  A Ljungh; M Eriksson; O Eriksson; J I Henter; T Wadström
Journal:  Scand J Infect Dis       Date:  1988

10.  Adoptive transfer of immune enhancement of experimental ulcerative colitis.

Authors:  A B Onderdonk; R M Steeves; R L Cisneros; R T Bronson
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more
  2 in total

1.  Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.

Authors:  Seth M Bloom; Vinieth N Bijanki; Gerardo M Nava; Lulu Sun; Nicole P Malvin; David L Donermeyer; W Michael Dunne; Paul M Allen; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

2.  Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice.

Authors:  Luoyi Zhu; Xin Zong; Xiao Xiao; Yuanzhi Cheng; Jie Fu; Zeqing Lu; Mingliang Jin; Fengqin Wang; Yizhen Wang
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.